NCT04553458View on ClinicalTrials.gov

Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma

CompletedOBSERVATIONAL
Enrollment

407

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Hepatocellular Carcinoma
Interventions
DEVICE

Radiofrequency ablation

Radiofrequency ablation of the tumour

DRUG

Trance-arterial chemoembolization

Trance-arterial chemotherapy

PROCEDURE

Liver resection

non-anatomical or anatomical liver resection

COMBINATION_PRODUCT

Combined radiofrequency ablation + percutaneous ethanol injection

combined therapy

DRUG

Percutaneous ethanol injection

Percutaneous ethanol injection of HCC

DRUG

Systemic chemotherapy

Systemic chemotherapy

DRUG

Sorafenib

Sorafenib

DIETARY_SUPPLEMENT

Viscum

Viscum for HCC

DRUG

Symptomatic treatment

Symptomatic treatment

All Listed Sponsors
lead

Sohag University

OTHER

NCT04553458 - Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter